Spots Global Cancer Trial Database for Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
Official Title: Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
Study ID: NCT05246345
Interventions
Study Description
Brief Summary: The purpose of this study is to collect medical informations and samples from refractory and/or relapsed chronic lymphocytic leukemia during or after venetoclax treatment, in order to evaluate the frequency of resistance mechanisms.
Detailed Description: The purpose of this study is to collect medical informations and samples (blood, bone marrow and/or lymph node) from refractory and/or relapsed chronic lymphocytic leukemia during or after venetoclax treatment, in order to evaluate the frequency of resistance mechanisms (BCL2 mutations, over-expression of other members of the BCL2 protein family and energy metabolism changes).
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU d'Amiens, Amiens, , France
CHU de Besançon, Besançon, , France
Hopital AVICENNE, Bobigny, , France
CHU clermont-ferrand, Clermont-Ferrand, , France
CHU de Clermont Ferrand, Clermont-Ferrand, , France
CHU Grenoble, Grenoble, , France
CHRU de Lille, Lille, , France
Centre LEON BERARD, Lyon, , France
CHU de Montpellier, Montpellier, , France
CHU Nancy, Nancy, , France
Hopital Pitié Salpetrière, Paris, , France
Hopital Haut LEVEQUE, Pessac, , France
CHU de Reims, Reims, , France
IUCT Oncopole, Toulouse, , France
Contact Details
Name: Romain GUIEZE
Affiliation: University Hospital, Clermont-Ferrand
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
